Who owns the WE ASPIRE TO CURE CANCER trademark?

The WE ASPIRE TO CURE CANCER trademark is owned by Millennium Pharmaceuticals, Inc..

What class is the WE ASPIRE TO CURE CANCER trademark registered in?

The WE ASPIRE TO CURE CANCER trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for WE ASPIRE TO CURE CANCER?

The USPTO serial number for WE ASPIRE TO CURE CANCER is 77732357.

What is the registration number for WE ASPIRE TO CURE CANCER?

WE ASPIRE TO CURE CANCER is registered under USPTO registration number 3739198.

WEA

USPTO Trademark Record

REGISTERED

WE ASPIRE TO CURE CANCER

SN 77732357·Reg 3739198·Filed May 08, 2009

Owner Millennium Pharmaceuticals, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

WE ASPIRE TO CURE CANCER (Serial No. 77732357), Registration No. 3739198, is a registered US trademark filed on May 08, 2009 by Millennium Pharmaceuticals, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Section 8/9 declaration window: January 21, 2030

Mark Intelligence

WE ASPIRE TO CURE CANCER (Reg. #3739198) is a registered US trademark that has been protecting its owner, Millennium Pharmaceuticals, Inc., since 2009. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 08, 2009

SERIAL

77732357

REG#

3739198

REGISTERED

Jan 19, 2010

Owner

Applicant

Millennium Pharmaceuticals, Inc.

Entity

Corporation

State

Address

40 Landsdowne Street, Cambridge, MA, 02139

Country

Attorney

NameKarl M. Zielaznicki, Esq.

Law firm

Karl M. Zielaznicki, Esq. Troutman Sanders LLP

Docket

255556000013

Address

875 Third Avenue, c/o IP Services NYC, New York, NY 10022, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMay 08, 2009

Serial Number77732357

Registration No.3739198

Registration DateJan 19, 2010

Status DateMar 09, 2020

Published for OppositionNov 03, 2009

Next RenewalJanuary 21, 2030

Mark TypeStandard characters

Attorney Docket255556000013

Status DescriptionLive and registered, renewed

Filing Signals

FILED

2009

YEARS AGO

17y

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Mar 15, 2009

First use in commerce: Mar 15, 2009

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

29 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Mar 09, 2020

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Mar 09, 2020

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Mar 09, 2020

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Mar 09, 2020

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

TEAS SECTION 8 & 9 RECEIVED

Jan 15, 2020

TEAS SECTION 8 & 9 RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 15, 2020

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Aug 22, 2019

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Aug 22, 2019

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Jan 19, 2019

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

Apr 05, 2017

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 31, 2017

CORRESPONDENCE RECEIVED IN LAW OFFICE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Mar 27, 2015

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Mar 27, 2015

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Mar 27, 2015

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

Mar 13, 2015

TEAS SECTION 8 & 15 RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jan 19, 2010

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Nov 03, 2009

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Oct 14, 2009

NOTICE OF PUBLICATION

ASSIGNED TO LIE

Sep 28, 2009

ASSIGNED TO LIE

LAW OFFICE PUBLICATION REVIEW COMPLETED

Sep 28, 2009

LAW OFFICE PUBLICATION REVIEW COMPLETED

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 16, 2009

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 03, 2009

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 31, 2009

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 31, 2009

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Aug 14, 2009

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION MAILED

Aug 14, 2009

NON-FINAL ACTION MAILED

ASSIGNED TO EXAMINER

Aug 06, 2009

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

May 12, 2009

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 12, 2009

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

WE ASPIRE TO CURE CANCER

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Millennium Pharmaceuticals, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Karl M. Zielaznicki, Esq.

Resources

Company